We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Cisco
CSCO
$478B
| $514K | 0.05% |
9,517
-25,321
| -73% | -$1.23M |
|
677
Oracle
ORCL
$421B
| $514K | 0.05% |
9,566
-39,263
| -80% | -$2M |
|
678
ResMed
RMD
$30.3B
| $514K | 0.05% |
+4,947
| New | +$511K |
|
|
WRK
679
DELISTED
WestRock Company
WRK
| $514K | 0.05% |
13,404
+7,382
| +123% | +$289K |
|
|
ATSG
680
DELISTED
Air Transport Services Group
ATSG
| $513K | 0.05% |
+22,266
| New | +$512K |
|
681
TriNet
TNET
$3.17B
| $512K | 0.05% |
8,564
+3,442
| +67% | +$182K |
|
|
VSI
682
DELISTED
Vitamin Shoppe Inc.
VSI
| $507K | 0.05% |
71,968
-6,062
| -8% | -$35.7K |
|
683
Consolidated Edison
ED
$40B
| $506K | 0.05% |
5,967
-2,203
| -27% | -$176K |
|
684
Ollie's Bargain Outlet
OLLI
$4.83B
| $506K | 0.05% |
5,931
-6,255
| -51% | -$504K |
|
685
Ball Corp
BALL
$16.8B
| $505K | 0.05% |
8,722
-4,743
| -35% | -$253K |
|
686
Equitable Holdings
EQH
$14.1B
| $505K | 0.05% |
+25,066
| New | +$478K |
|
687
SBA Communications
SBAC
$19.6B
| $505K | 0.05% |
+2,528
| New | +$458K |
|
688
SPX Corp
SPXC
$10.8B
| $504K | 0.05% |
+14,499
| New | +$471K |
|
|
MTOR
689
DELISTED
MERITOR, Inc.
MTOR
| $504K | 0.05% |
+24,777
| New | +$504K |
|
690
Rocky Brands
RCKY
$370M
| $503K | 0.05% |
20,982
-318
| -1% | -$8.64K |
|
691
Accuray
ARAY
$35.7M
| $502K | 0.05% |
105,298
+78,298
| +290% | +$356K |
|
|
MZTI
692
The Marzetti Company
MZTI
$3.05B
| $502K | 0.05% |
3,203
+1,803
| +129% | +$290K |
|
|
ZVO
693
DELISTED
Zovio Inc. Common Stock
ZVO
| $502K | 0.05% |
82,213
-953
| -1% | -$7.68K |
|
694
Toro Company
TTC
$9.49B
| $501K | 0.05% |
7,280
+3,105
| +74% | +$197K |
|
695
United Airlines
UAL
$41.9B
| $501K | 0.05% |
6,278
-36,515
| -85% | -$3.08M |
|
|
ACHN
696
DELISTED
Achillion Pharmaceuticals
ACHN
| $501K | 0.05% |
169,369
-34,600
| -17% | -$85K |
|
|
VIAB
697
DELISTED
Viacom Inc. Class B
VIAB
| $499K | 0.05% |
17,772
+1,981
| +13% | +$56.9K |
|
|
EE
698
DELISTED
El Paso Electric Company
EE
| $498K | 0.05% |
8,464
-7,849
| -48% | -$423K |
|
|
TPCO
699
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $497K | 0.05% |
42,193
-24,677
| -37% | -$289K |
|
700
Mesa Laboratories
MLAB
$573M
| $496K | 0.05% |
+2,151
| New | +$486K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.